Loading…
Reported covered position: Sr. Counsel and Dir. External Affairs - HHS OIG; Prin. Dep. Administrator for Policy and Operations and Dir. of Medicare Program Integrity - CMS; Chief Oversight and General Counsel - Senate Cmte. on Finance
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
American Relief Act, 2025
Client: JAZZ PHARMACEUTICALS INC. · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 8467 - Farm, Food, and National Security Act of 2024 H.R. 10545 - American Relief Act of 2025 Drug safety, prescription drug abuse, value of prescription drugs
American Relief Act, 2025
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 3435 - the Charitable Act S. 566 - the Charitable Act H.R. 10545 American Relief Act of 2025 H.R.5894 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
LINCARE via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
competitive bidding, durable medical equipment, Medicare coverage and reimbursement, home care, remote patient monitoring
Federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Source: Senate LDA
| GENENTECH INC | 19 | 2021–2024 |
| GENTIVA (FORMERLY REPORTED AS HUMANA & KINDRED AT HOME) | 19 | 2021–2024 |
| ABBOTT (FORMERLY KNOWN AS ALERE INC.) | 18 | 2021–2024 |
| ABBVIE, INC. | 18 | 2021–2024 |
| AMERICAN CANCER SOCIETY CANCER ACTION NETWORK (ACSCAN) | 18 | 2021–2024 |
| AMERICAN OSTEOPATHIC ASSOCIATION | 18 | 2021–2024 |
| AMGEN, INC. | 18 | 2021–2024 |
| BD (BECTON, DICKINSON AND COMPANY) | 18 | 2021–2024 |
| BLUE CROSS AND BLUE SHIELD ASSOCIATION | 18 | 2021–2024 |
| BOEHRINGER INGELHEIM | 18 | 2021–2024 |
| ELEVANCE HEALTH, INC (F.K.A. ANTHEM, INC. & WELLPOINT, INC.) | 18 | 2021–2024 |
| ELI LILLY AND COMPANY | 18 | 2021–2024 |
| FOUNDATION MEDICINE | 18 | 2021–2024 |
| GILEAD SCIENCES, INC. | 18 | 2021–2024 |
| HEALTH CARE SERVICE CORPORATION | 18 | 2021–2024 |
| HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) | 18 | 2021–2024 |
| THE AMPUTEE COALITION | 18 | 2021–2024 |
| ACCENTURE FEDERAL SERVICES | 17 | 2021–2024 |
| BRISTOL MYERS SQUIBB | 17 | 2021–2024 |
| GAINWELL TECHNOLOGIES (FKA HEALTH MANAGEMENT SYSTEMS) | 17 | 2021–2024 |
| JAZZ PHARMACEUTICALS INC. | 17 | 2021–2024 |
| LINCARE | 17 | 2021–2024 |
| LONGEVITY HEALTH PLAN | 17 | 2021–2024 |
| MERCK | 17 | 2021–2024 |
| NOVO NORDISK, INC. | 17 | 2021–2024 |
| PHRMA | 17 | 2021–2024 |
| SANOFI US SERVICES INC (FORMERLY KNOWN AS GENZYME CORPORATION) | 17 | 2021–2024 |
| SAREPTA THERAPEUTICS | 17 | 2021–2024 |
| THORN RUN PARTNERS (ON BEHALF OF THE PARTNERSHIP TO IMPROVE PATIENT CARE) | 17 | 2021–2024 |
| TRIPLE-S MANAGEMENT CORPORATION | 17 | 2021–2024 |
| AIS HEALTHCARE | 16 | 2021–2024 |
| NOVOCURE INC. | 16 | 2021–2024 |
| 10X GENOMICS | 14 | 2021–2023 |
| NEUROCRINE BIOSCIENCES, INC | 14 | 2021–2023 |
| AMYLYX PHARMACEUTICALS | 13 | 2022–2024 |
| FLAGSHIP PIONEERING | 13 | 2022–2024 |
| NATIONAL ELECTRICAL MANUFACTURERS ASSOCIATION (MITA) | 13 | 2021–2023 |
| ONE MEDICAL | 13 | 2021–2023 |
| SAS | 13 | 2022–2024 |
| MEDICAL FACULTY ASSOCIATES, INC. | 12 | 2021–2022 |
| HEALTHCARE LEADERSHIP COUNCIL | 11 | 2021–2023 |
| MEDICALLY HOME | 11 | 2022–2024 |
| AMERICAN INVESTMENT COUNCIL | 10 | 2023–2024 |
| BAXTER | 9 | 2021–2022 |
| NOVARTIS | 9 | 2023–2024 |
| OPTION CARE HEALTH | 9 | 2023–2024 |
| QUEST DIAGNOSTICS | 9 | 2023–2024 |
| VALNEVA USA, INC | 9 | 2023–2024 |
| MALLINCKRODT PHARMACEUTICALS | 8 | 2021–2022 |
| OTSUKA AMERICA PHARMACEUTICAL, INC. | 8 | 2021–2022 |
| SIGNIFY (F.K.A. REMEDY BPCI PARTNERS, LLC) | 8 | 2021–2022 |
| EXCELLUS HEALTH PLAN INC. | 7 | 2023–2024 |
| AMAZON.COM SERVICES LLC | 6 | 2024 |
| CALIFORNIA PROTONS CANCER THERAPY CENTER | 6 | 2021–2022 |
| H2 HEALTH | 6 | 2021–2022 |
| OCTAVIANT FINANCIAL INC. | 6 | 2023–2024 |
| OPEN PHILANTHROPY ACTION FUND | 6 | 2021–2022 |
| TAKEDA PHARMACEUTICALS AMERICA INC | 6 | 2021–2022 |
| ADVAMED | 5 | 2024 |
| ADVOCATES FOR COMMUNITY HEALTH | 5 | 2023 |
| AMNEAL PHARMACEUTICALS, INC. | 5 | 2024 |
| CRINETICS PHARMACEUTICALS | 5 | 2024 |
| EVERGREEN NEPHROLOGY | 5 | 2024 |
| HEALTH GORILLA | 5 | 2023 |
| ASTELLAS PHARMA US, INC. | 4 | 2024 |
| AVAILITY | 4 | 2024 |
| Hims & Hers Health, Inc. | 4 | 2023–2024 |
| NATIONAL SEATING & MOBILITY | 4 | 2024 |
| HANSA BIOPHARMA | 3 | 2024 |
| NORWEGIAN CRUISE LINE HOLDINGS | 2 | 2021 |
PSA Screening for HIM Act
Client: ASTELLAS PHARMA US, INC · Firm: TARPLIN, DOWNS & YOUNG, LLC
The PSA Screening for HIM Act (H.R. 1826/S. 2821) menopause, drug pricing
PSA Screening for HIM Act
Client: ASTELLAS PHARMA US, INC · Firm: TARPLIN, DOWNS & YOUNG, LLC
The PSA Screening for HIM Act (H.R. 1826/S. 2821) menopause, drug pricing
PSA Screening for HIM Act
Client: ASTELLAS PHARMA US, INC · Firm: TARPLIN, DOWNS & YOUNG, LLC
The PSA Screening for HIM Act (H.R. 1826/S. 2821) menopause, drug pricing
Special Diabetes Program Reauthorization Act of 2023
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
S. 4504/H.R. 8698 - SCREEN for Type 1 Diabetes Act S. 1855/H.R. 2550 - Special Diabetes Program Reauthorization Act of 2023 S. 1269 - INSULIN Act of 2023 H.R. 4758/S.2372, Accelerating Kids Access to Care Act (AKAC) S. 3234, Chronic Disease Flexible Coverage Act
Making further continuing appropriations for the fiscal year ending September 30, 2024, and for other purposes.
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 2872 - Further Additional Continuing Appropriations and Other Extensions Act, 2024 H.R. 4366 - Consolidated Appropriations Act of 2024 H.R. 7463 - the Extension of Continuing Appropriations and Other Matters Act S. 4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025 Issues pertaining to NIH appropriations for FY25
Making further continuing appropriations for the fiscal year ending September 30, 2024, and for other purposes.
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 2872 - Further Additional Continuing Appropriations and Other Extensions Act, 2024 H.R. 4366 - Consolidated Appropriations Act of 2024 H.R. 7463 - the Extension of Continuing Appropriations and Other Matters Act Issues pertaining to NIH appropriations for FY25
Making further continuing appropriations for the fiscal year ending September 30, 2024, and for other purposes.
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 2872 - Further Additional Continuing Appropriations and Other Extensions Act, 2024 H.R. 4366 - Consolidated Appropriations Act of 2024 H.R. 7463 - the Extension of Continuing Appropriations and Other Matters Act Issues pertaining to NIH appropriations for FY25
Further Consolidated Appropriations Act, 2024
Client: JAZZ PHARMACEUTICALS INC. · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 4336, the Consolidated Appropriations Act, 2024 (P.L. 118-42) H.R. 2882, the Further Consolidated Appropriations Act, 2024 (P.L. 118-47) Drug safety, prescription drug abuse, value of prescription drugs, expiring healthcare extenders
To amend title XI of the Social Security Act to increase transparency of certain health-related ownership information.
Client: AMERICAN INVESTMENT COUNCIL · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 3262 H.R. 3561 Legislation affecting the regulation of private equity, and other proposals related to equitable treatment of private equity in health care.
To amend title XI of the Social Security Act to increase transparency of certain health-related ownership information.
Client: AMERICAN INVESTMENT COUNCIL · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 3262 H.R. 3561 Legislation affecting the regulation of private equity, and other proposals related to equitable treatment of private equity in health care, private equity ownership with healthcare entities
To amend title XI of the Social Security Act to increase transparency of certain health-related ownership information.
Client: AMERICAN INVESTMENT COUNCIL · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 3262 H.R. 3561 Legislation affecting the regulation of private equity, and other proposals related to equitable treatment of private equity in health care, private equity ownership with healthcare entities
To amend title XI of the Social Security Act to increase transparency of certain health-related ownership information.
Client: AMERICAN INVESTMENT COUNCIL · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 3262 H.R. 3561 Legislation affecting the regulation of private equity, and other proposals related to equitable treatment of private equity in health care, private equity ownership with healthcare entities
Charitable Act
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 3435 - the Charitable Act S. 566 - the Charitable Act H.R. 10545 American Relief Act of 2025 H.R.5894 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes
American Broadband Deployment Act of 2023
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
American Broadband Deployment Act of 2023
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
American Broadband Deployment Act of 2023
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
American Broadband Deployment Act of 2023
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act H.R.9540 - Fight Illicit Pill Presses Act of 2024 H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act H.R. 7623, Telehealth Modernization Act of 2024 General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
H.R. 3262 H.R. 3561 Legislation affecting the regulation of private equity, and other proposals related to equitable treatment of private equity in health care, private equity ownership with healthcare entities
H.R. 3262 H.R. 3561 Legislation affecting the regulation of private equity, and other proposals related to equitable treatment of private equity in health care, private equity ownership with healthcare entities
H.R. 3262 H.R. 3561 Legislation affecting the regulation of private equity, and other proposals related to equitable treatment of private equity in health care, private equity ownership with healthcare entities
H.R. 3262 H.R. 3561 Legislation affecting the regulation of private equity, and other proposals related to equitable treatment of private equity in health care.
State Strategic Stockpile Act of 2023
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
State Strategic Stockpile Act of 2023
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
State Strategic Stockpile Act of 2023
Client: VALNEVA USA, INC · Firm: TARPLIN, DOWNS & YOUNG, LLC
S.2080 Strengthening America's Strategic National Stockpile Act H.R.3631 State Strategic Stockpile Act vaccine access, pandemic preparedness, PAHPA reauthorization
State Strategic Stockpile Act of 2023
Client: VALNEVA USA, INC · Firm: TARPLIN, DOWNS & YOUNG, LLC
S.2080 Strengthening America's Strategic National Stockpile Act H.R.3631 State Strategic Stockpile Act vaccine access, pandemic preparedness, PAHPA reauthorization
State Strategic Stockpile Act of 2023
Client: VALNEVA USA, INC · Firm: TARPLIN, DOWNS & YOUNG, LLC
S.2080 Strengthening America's Strategic National Stockpile Act H.R.3631 State Strategic Stockpile Act vaccine access, pandemic preparedness, PAHPA reauthorization
State Strategic Stockpile Act of 2023
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
State Strategic Stockpile Act of 2023
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act H.R.9540 - Fight Illicit Pill Presses Act of 2024 H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act H.R. 7623, Telehealth Modernization Act of 2024 General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
State Strategic Stockpile Act of 2023
Client: VALNEVA USA, INC · Firm: TARPLIN, DOWNS & YOUNG, LLC
S.2080 Strengthening America's Strategic National Stockpile Act H.R.3631 State Strategic Stockpile Act vaccine access, pandemic preparedness, PAHPA reauthorization
Improving Public Health Preparedness Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Improving Public Health Preparedness Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Improving Public Health Preparedness Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act H.R.9540 - Fight Illicit Pill Presses Act of 2024 H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act H.R. 7623, Telehealth Modernization Act of 2024 General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Improving Public Health Preparedness Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
SCREENS for Cancer Act of 2024
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK (ACSCAN) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.3916/S.1840 - SCREENS for Cancer Act of 2023 IRA implementation, childhood cancer, access and coverage, prescription drug pricing and access, health disparities, cancer screenings, prostate cancer screenings, PCHETA, MCED
SCREENS for Cancer Act of 2024
Client: AMERICAN CANCER SOCIETY CANCER ACTION NETWORK (ACSCAN) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.3916/S.1840 - SCREENS for Cancer Act of 2023 IRA implementation, childhood cancer, access and coverage, prescription drug pricing and access, health disparities, cancer screenings, prostate cancer screenings, PCHETA, MCED
Essential Medicines Strategic Stockpile Act of 2023
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Essential Medicines Strategic Stockpile Act of 2023
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act H.R.9540 - Fight Illicit Pill Presses Act of 2024 H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act H.R. 7623, Telehealth Modernization Act of 2024 General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Essential Medicines Strategic Stockpile Act of 2023
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Essential Medicines Strategic Stockpile Act of 2023
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Preserving Patient Access to Home Infusion Act
Client: OPTION CARE HEALTH · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.4104/S.1976 - Preserving Patient Access to Home Infusion Act Medicare coverage and payment for home infusion services
Preserving Patient Access to Home Infusion Act
Client: OPTION CARE HEALTH · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.4104/S.1976 - Preserving Patient Access to Home Infusion Act Medicare coverage and payment for home infusion services
Summer Meals REACH Act of 2023
Client: JAZZ PHARMACEUTICALS INC. · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 4336, the Consolidated Appropriations Act, 2024 (P.L. 118-42) H.R. 2882, the Further Consolidated Appropriations Act, 2024 (P.L. 118-47) Drug safety, prescription drug abuse, value of prescription drugs, expiring healthcare extenders
Consolidated Appropriations Act, 2024
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 2872 - Further Additional Continuing Appropriations and Other Extensions Act, 2024 H.R. 4366 - Consolidated Appropriations Act of 2024 H.R. 7463 - the Extension of Continuing Appropriations and Other Matters Act Issues pertaining to NIH appropriations for FY25
Consolidated Appropriations Act, 2024
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 2872 - Further Additional Continuing Appropriations and Other Extensions Act, 2024 H.R. 4366 - Consolidated Appropriations Act of 2024 H.R. 7463 - the Extension of Continuing Appropriations and Other Matters Act S. 4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025 Issues pertaining to NIH appropriations for FY25
Consolidated Appropriations Act, 2024
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 2872 - Further Additional Continuing Appropriations and Other Extensions Act, 2024 H.R. 4366 - Consolidated Appropriations Act of 2024 H.R. 7463 - the Extension of Continuing Appropriations and Other Matters Act Issues pertaining to NIH appropriations for FY25
Preparing for All Hazards and Pathogens Reauthorization Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Preparing for All Hazards and Pathogens Reauthorization Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Preparing for All Hazards and Pathogens Reauthorization Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Preparing for All Hazards and Pathogens Reauthorization Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act H.R.9540 - Fight Illicit Pill Presses Act of 2024 H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act H.R. 7623, Telehealth Modernization Act of 2024 General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Small Business Tax Fairness and Compliance Simplification Act
Client: THORN RUN PARTNERS (ON BEHALF OF THE PARTNERSHIP TO IMPROVE PATIENT CARE) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.45 - Small Business Tax Fairness and Compliance Simplification Act IRA implementation, patient engagement, alternative payment models
Support for Patients and Communities Reauthorization Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act H.R.9540 - Fight Illicit Pill Presses Act of 2024 H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act H.R. 7623, Telehealth Modernization Act of 2024 General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Support for Patients and Communities Reauthorization Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Support for Patients and Communities Reauthorization Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Support for Patients and Communities Reauthorization Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Accelerating Kids’ Access to Care Act
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
S. 4504/H.R. 8698 - SCREEN for Type 1 Diabetes Act S. 1855/H.R. 2550 - Special Diabetes Program Reauthorization Act of 2023 S. 1269 - INSULIN Act of 2023 H.R. 4758/S.2372, Accelerating Kids Access to Care Act (AKAC) S. 3234, Chronic Disease Flexible Coverage Act
Treat and Reduce Obesity Act of 2023
Client: ELI LILLY AND COMPANY · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.4818 - Treat and Reduce Obesity Act of 2023 Medicare & Medicaid payments and coverage issues, Medicare Part D, Medicare Part B, 340B
Treat and Reduce Obesity Act of 2023
Client: ELI LILLY AND COMPANY · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.4818 - Treat and Reduce Obesity Act of 2023 Medicare & Medicaid payments and coverage issues, Medicare Part D, Medicare Part B, 340B
Treat and Reduce Obesity Act of 2023
Client: ELI LILLY AND COMPANY · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.4818 - Treat and Reduce Obesity Act of 2023 Medicare & Medicaid payments and coverage issues, Medicare Part D, Medicare Part B, 340B
Protecting Health Care for All Patients Act of 2023
Client: THORN RUN PARTNERS (ON BEHALF OF THE PARTNERSHIP TO IMPROVE PATIENT CARE) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.485 - Protecting Health Care for All Patients Act of 2023 IRA implementation, patient engagement, alternative payment models
Protecting Health Care for All Patients Act of 2023
Client: THORN RUN PARTNERS (ON BEHALF OF THE PARTNERSHIP TO IMPROVE PATIENT CARE) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.485 - Protecting Health Care for All Patients Act of 2023 IRA implementation, patient engagement, alternative payment models
H.R. 5378: Lower Costs, More Transparency Act 340B, transparency, prescription drug pricing and access, beneficiary access, IRA implementation
Lower Costs, More Transparency Act
Client: ELI LILLY AND COMPANY · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, non-interference, drug shortages, prescription drug access and affordability, transparency, insulin policy, 340B
Lower Costs, More Transparency Act
Client: BRISTOL MYERS SQUIBB · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act Prescription drug access and affordability, pricing, transparency, biosimilars, 340B
H.R. 5378: Lower Costs, More Transparency Act S.476/H.R. 5547 Maintaining Investments in New Innovation (MINI) Act IRA implementation, 340B, affordability, pharmaceutical innovation, transparency, intellectual property, kidney care policies, PBMs, pharmaceutical pricing issues, drug shortages, genetically targeted therapies
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, innovation, 340B, hepatitis C, HPV, transparency, drug pricing, vaccines, biosimilars
H.R. 5378: Lower Costs, More Transparency Act 340B, transparency, prescription drug pricing and access, beneficiary access, IRA implementation
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, innovation, 340B, hepatitis C, HPV, transparency, drug pricing, vaccines, biosimilars
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, supply chain integrity, innovation, 340B, transparency
Lower Costs, More Transparency Act
Client: ELI LILLY AND COMPANY · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, non-interference, drug shortages, prescription drug access and affordability, transparency, insulin policy, 340B
H.R. 5378: Lower Costs, More Transparency Act S.476/H.R. 5547 Maintaining Investments in New Innovation (MINI) Act IRA implementation, 340B, affordability, pharmaceutical innovation, transparency, intellectual property, PBMs, pharmaceutical pricing issues, drug shortages, genetically targeted therapies
Lower Costs, More Transparency Act
Client: BOEHRINGER INGELHEIM · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, prescription drug pricing, prescription drug access and affordability, transparency, 340B
H.R. 5378: Lower Costs, More Transparency Act 340B, transparency, prescription drug pricing and access, beneficiary access, IRA implementation, FY25 appropriations
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, innovation, 340B, hepatitis C, HPV, transparency, drug pricing, vaccines, biosimilars
Lower Costs, More Transparency Act
Client: BOEHRINGER INGELHEIM · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, prescription drug pricing, prescription drug access and affordability, transparency
Lower Costs, More Transparency Act
Client: ELI LILLY AND COMPANY · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, non-interference, drug shortages, prescription drug access and affordability, transparency, insulin policy, 340B
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, supply chain integrity, innovation, 340B, transparency
Lower Costs, More Transparency Act
Client: BOEHRINGER INGELHEIM · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, prescription drug pricing, prescription drug access and affordability, transparency
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, 340B, affordability, pharmaceutical innovation, transparency, intellectual property, kidney care policies, PBMs, pharmaceutical pricing issues, drug shortages, genetically targeted therapies
H.R. 5378: Lower Costs, More Transparency Act S.476/H.R. 5547 Maintaining Investments in New Innovation (MINI) Act IRA implementation, 340B, affordability, pharmaceutical innovation, transparency, intellectual property, PBMs, pharmaceutical pricing issues, drug shortages, genetically targeted therapies
Lower Costs, More Transparency Act
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
Implementation of the special diabetes program, renewal of the special diabetes program, artificial pancreas program, NIH, innovation in drug development for diabetes, insulin access and affordability H.R. 5378 Lower Costs, More Transparency Act S. 1269 - INSULIN Act of 2023 S. 1855 Special Diabetes Program Reauthorization Act of 2023
Lower Costs, More Transparency Act
Client: BOEHRINGER INGELHEIM · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, prescription drug pricing, prescription drug access and affordability, transparency, 340B
Lower Costs, More Transparency Act
Client: BRISTOL MYERS SQUIBB · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, prescription drug access and affordability, pricing, transparency, biosimilars
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, supply chain integrity, innovation, 340B, transparency
Lower Costs, More Transparency Act
Client: BRISTOL MYERS SQUIBB · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, prescription drug access and affordability, pricing, transparency, biosimilars, 340B
Maintaining Investments in New Innovation Act
Client: NOVARTIS · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act S.476/H.R. 5547 Maintaining Investments in New Innovation (MINI) Act IRA implementation, 340B, affordability, pharmaceutical innovation, transparency, intellectual property, PBMs, pharmaceutical pricing issues, drug shortages, genetically targeted therapies
Maintaining Investments in New Innovation Act
Client: NOVARTIS · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act S.476/H.R. 5547 Maintaining Investments in New Innovation (MINI) Act IRA implementation, 340B, affordability, pharmaceutical innovation, transparency, intellectual property, PBMs, pharmaceutical pricing issues, drug shortages, genetically targeted therapies
Maintaining Investments in New Innovation Act
Client: NOVARTIS · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5378: Lower Costs, More Transparency Act S.476/H.R. 5547 Maintaining Investments in New Innovation (MINI) Act IRA implementation, 340B, affordability, pharmaceutical innovation, transparency, intellectual property, kidney care policies, PBMs, pharmaceutical pricing issues, drug shortages, genetically targeted therapies
Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes.
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 3435 - the Charitable Act S. 566 - the Charitable Act H.R. 10545 American Relief Act of 2025 H.R.5894 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes
Further Continuing Appropriations and Other Extensions Act, 2024
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
Federal budget issues H.R. 6363 - Further Continuing Appropriations and Other Extensions Act, 2024
MAPS Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act H.R.9540 - Fight Illicit Pill Presses Act of 2024 H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act H.R. 7623, Telehealth Modernization Act of 2024 General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
MAPS Act
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Alternatives to PAIN Act
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.7142/S.3838 Alternatives to PAIN Act IRA implementation, innovation, health disparities, orphan drugs, 340B, opioid alternative medicine, SUPPORT Act reauthorization
Alternatives to PAIN Act
Client: VERTEX PHARMACEUTICALS INCORPORATED · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.7142/S.3838 Alternatives to PAIN Act IRA implementation, innovation, health disparities, orphan drugs, 340B, opioid alternative medicine, SUPPORT Act reauthorization
Extension of Continuing Appropriations and Other Matters Act, 2024
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 2872 - Further Additional Continuing Appropriations and Other Extensions Act, 2024 H.R. 4366 - Consolidated Appropriations Act of 2024 H.R. 7463 - the Extension of Continuing Appropriations and Other Matters Act Issues pertaining to NIH appropriations for FY25
Extension of Continuing Appropriations and Other Matters Act, 2024
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 2872 - Further Additional Continuing Appropriations and Other Extensions Act, 2024 H.R. 4366 - Consolidated Appropriations Act of 2024 H.R. 7463 - the Extension of Continuing Appropriations and Other Matters Act Issues pertaining to NIH appropriations for FY25
Extension of Continuing Appropriations and Other Matters Act, 2024
Client: BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 2872 - Further Additional Continuing Appropriations and Other Extensions Act, 2024 H.R. 4366 - Consolidated Appropriations Act of 2024 H.R. 7463 - the Extension of Continuing Appropriations and Other Matters Act S. 4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025 Issues pertaining to NIH appropriations for FY25
Telehealth Modernization Act of 2024
Client: HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) · Firm: TARPLIN, DOWNS & YOUNG, LLC
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act H.R.9540 - Fight Illicit Pill Presses Act of 2024 H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act H.R. 7623, Telehealth Modernization Act of 2024 General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Dr. Michael C. Burgess Preventive Health Savings Act
Client: FLAGSHIP PIONEERING · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R.766/S.114 Preventive Health Savings Act Pandemic preparedness, life science innovation and competitiveness, preemptive health and medicine, biomanufacturing, next generation vaccines and therapeutics, PAPHA reauthorization, AI policy and regulation, AMR research
2024 · fourth_quarter · Q4
Federal budget issues
bio pharmaceutical reimbursement issues, IRA implementation
H.R. 5378: Lower Costs, More Transparency Act S.476/H.R. 5547 Maintaining Investments in New Innovation (MINI) Act IRA implementation, 340B, affordability, pharmaceutical innovation, transparency, intellectual property, PBMs, pharmaceutical pricing issues, drug shortages, genetically targeted therapies
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMNEAL PHARMACEUTICALS, INC. via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
drug shortages, critical medicines limited to antibiotics and antimicrobials
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SANOFI US SERVICES INC (FORMERLY KNOWN AS GENZYME CORPORATION) via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
IRA implementation, supply chain integrity, 340B, orphan drugs, newborn screening, expanded access, transparency, drug shortages, drug pricing, insulin, diabetes screening, COPD
federal budget issues
IRA implementation, transparency, vaccines, coverage and access
orphan drug tax credit, vaccine policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
Federal budget issues
IRA implementation, innovation, 340B, orphan drugs, PAPHA reauthorization, competitiveness, supply chain, vaccine access and coverage
Vaccine policy
Medicare & Medicaid payment and coverage issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SAS via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
Medicaid redeterminations, nursing home ownership transparency, IRA implementation, medical review pilot, data use by Medicare Administrative Contractors
Medicaid redeterminations, nursing home ownership transparency
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
JAZZ PHARMACEUTICALS INC. via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
H.R. 8467 - Farm, Food, and National Security Act of 2024 H.R. 10545 - American Relief Act of 2025 Drug safety, prescription drug abuse, value of prescription drugs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAREPTA THERAPEUTICS via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
Medicaid drug rebate program, coverage, state program operations, waivers, gene therapy, value based contracting, Medicaid value based payment rule
Federal budget issues
Innovation, Duchenne Muscular Dystrophy, platform technologies, value based contracting, gene therapy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
GILEAD SCIENCES, INC. via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
IRA implementation, pharmaceutical access and affordability, 340B, HCV screening, drug pricing and access, HIV, oncology, PAPHA reauthorization, transparency
Medicare & Medicaid payment and coverage issues
Federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CRINETICS PHARMACEUTICALS via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
Innovation, prescription drug pricing
Medicare policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ASTELLAS PHARMA US, INC via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
The PSA Screening for HIM Act (H.R. 1826/S. 2821) menopause, drug pricing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACCENTURE FEDERAL SERVICES via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
federal budget issues, changes to the organ national transplant program
operational and contract issues
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
AMERICAN INVESTMENT COUNCIL via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
H.R. 3262 H.R. 3561 Legislation affecting the regulation of private equity, and other proposals related to equitable treatment of private equity in health care, private equity ownership with healthcare entities
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ABBVIE INC. via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
Federal budget issues
340B, transparency, prescription drug pricing and access, beneficiary access, IRA implementation
Part B, Part D, drug pricing and access, negotiation
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
BRISTOL MYERS SQUIBB via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
Federal budget issues
IRA implementation, Medicare & Medicaid payment and coverage issues
Prescription drug access and affordability, pricing, transparency, 340B
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
S. 4504/H.R. 8698 - SCREEN for Type 1 Diabetes Act S. 1855/H.R. 2550 - Special Diabetes Program Reauthorization Act of 2023 S. 1269 - INSULIN Act of 2023 H.R. 4758/S.2372, Accelerating Kids Access to Care Act (AKAC) S. 3234, Chronic Disease Flexible Coverage Act
H.R. 3435 - the Charitable Act S. 566 - the Charitable Act H.R. 10545 American Relief Act of 2025 H.R.5894 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2024, and for other purposes
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AVAILITY via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
Federal cybersecurity standards regulation of clearing houses
Federal cybersecurity standards regulation of clearing houses
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
MERCK via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
Federal budget issues
IRA implementation, innovation, 340B, hepatitis C, HPV, transparency, drug pricing, vaccines, biosimilars, PAHPA
patent reform, product hopping legislation
FLAGSHIP PIONEERING via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
Federal budget issues
H.R.766/S.114 Preventive Health Savings Act Pandemic preparedness, life science innovation and competitiveness, preemptive health and medicine, biomanufacturing, next generation vaccines and therapeutics, PAPHA reauthorization, AI policy and regulation, AMR research, rare disease PRV, ag-biotech policy and regulation
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
OPTION CARE HEALTH via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
Federal budget issues
H.R.4104/S.1976 - Preserving Patient Access to Home Infusion Act Medicare coverage and payment for home infusion services
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
AMGEN INC via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
federal budget issues
Medicare coverage and reimbursement issues, Medicare Part B reimbursement, transparency, prescription drug pricing and access, 340B
IRA implementation, 340B, biosimilars, orphan drugs, prescription drug access & reimbursement, FDA issues, transparency
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ADVAMED via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
Medicare coverage regulation and reimbursement of imaging services, Medicare physician payment, equipment maintenance, coding, HOPPS, E&M codes/budget neutrality, AI coverage and reimbursement
Imaging policy, device regulation, innovation, radiopharmaceuticals, coverage decisions, AI, device shortages, device servicing and manufacturing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALZHEIMER'S ASSOCIATION via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
federal budget issues
care planning, home and community based care, innovation, NAPA, BOLD Act, Advancing America's Interests Act
Medicare & Medicaid coverage and reimbursement issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
Opioid Abuse - General issues related to opioid abuse and access to medication assisted treatment HR 1770/S. 2477 - Equitable Community Access to Pharmacist Services Act Implementation of Public Law 113-54 (DSCSA)
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
Filing targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
VERTEX PHARMACEUTICALS INCORPORATED via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
H.R.7142/S.3838 Alternatives to PAIN Act IRA implementation, innovation, health disparities, orphan drugs, 340B, opioid alternative medicine, SUPPORT Act reauthorization
Medicare & Medicaid payment and coverage issues
federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
VALNEVA USA, INC via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
S.2080 Strengthening America's Strategic National Stockpile Act H.R.3631 State Strategic Stockpile Act vaccine access, pandemic preparedness, PAHPA reauthorization
Federal budget issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
TRIPLE-S MANAGEMENT CORPORATION via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
health disparities, social determinates of health
Federal budget issues
Medicare Advantage, Medicare Advantage benchmarks, Medicare reimbursement, dual eligible, Medicare physician payment
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THORN RUN PARTNERS (ON BEHALF OF THE PARTNERSHIP TO IMPROVE PATIENT CARE) via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
H.R.485 - Protecting Health Care for All Patients Act of 2023 IRA implementation, patient engagement, alternative payment models
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
QUEST DIAGNOSTICS via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
physician fee schedule
diagnostics, clinical lab reimbursement issues, savings access to lab service
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHRMA via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
Federal budget issues
IRA implementation, supply chain integrity, innovation, 340B, transparency
Medicare & Medicaid payment and coverage issues, transparency, 340B
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL SEATING & MOBILITY via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
mobility issues, durable medical equipment
mobility issues, durable medical equipment
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NOVOCURE INC. via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
IRA implementation, FDA policies
Medicare coverage and reimbursement, national coverage determinations, skilled nursing facility bundled payment policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NOVO NORDISK INC. via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
IRA implementation, medication affordability and access, general diabetes prevention, obsesity
Federal budget issues
Treat and Reduce Obesity Act, obesity treatment
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
LONGEVITY HEALTH PLAN via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
institutional special needs plans issues and policies
S. 3950 Duels Act of 2024 institutional special needs plans, Medicare Advantage, network adequacy, duel eligibles
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ELI LILLY AND COMPANY via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
Federal budget issues
IRA implementation, non-interference, drug shortages, prescription drug access and affordability, transparency, insulin policy, 340B
H.R.4818 - Treat and Reduce Obesity Act of 2023 Medicare & Medicaid payments and coverage issues, Medicare Part D, Medicare Part B, 340B
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTH CARE SERVICE CORPORATION via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
access and affordability
Medicare & Medicaid payment and coverage issues, Medicare Advantage
Issues related to tax advantage savings vehicles for health expenses
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HANSA BIOPHARMA via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
Kidney issues, access to innovation, rare disease issues
Filing targets: Health & Human Services, Dept of (HHS)
GENTIVA (FORMERLY REPORTED AS HUMANA & KINDRED AT HOME) via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
hospice reimbursement and policy issues
hospice care
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
GAINWELL TECHNOLOGIES (FKA HEALTH MANAGEMENT SYSTEMS) via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
Federal budget issues
Program integrity, redeterminations, Medicaid payment and policies, federal employee health benefit program auditing
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FOUNDATION MEDICINE via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
companion diagnostics, payment issues
LDT, companion diagnostics, testing, innovation, lab transparency, PAPHA reauthorization, early detection screening
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EXCELLUS HEALTH PLAN, INC. via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
H.R.8561 Medicare Advantage, Medicare reimbursement and payment issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EVERGREEN NEPHROLOGY via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · 4T
Medicare reimbursement
Federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ELEVANCE HEALTH, INC (F.K.A. ANTHEM, INC. & WELLPOINT, INC.) via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
Issues related to tax advantage savings vehicles for health expenses
Federal budget issues
health care access and quality issues
CARDINAL HEALTH (F.K.A. THE GLOVER PARK GROUP) via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
federal budget issues
General issues related to drug shortages, supply chain
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BOEHRINGER INGELHEIM via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
Federal budget issues
Medicare & Medicaid coverage and payment issues, regulatory and payment issues, IRA implementation
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, prescription drug pricing, prescription drug access and affordability, transparency, 340B
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BD (BECTON, DICKINSON AND COMPANY) via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
supply chain, US competitiveness
Medicare coverage and reimbursement, diagnostics
IRA implementation, diagnostics, supply chain, privacy
BLUE CROSS BLUE SHIELD ASSOCIATION via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
Medicare Advantage, telehealth, coverage, health savings accounts, transparency
Issues related to tax advantage savings vehicles for health expenses
Medicare & Medicaid payment and coverage issues
ASTRAZENECA via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
Federal budget issues
IRA implementation, 340B, orphan drug issues, oncology, transparency
Medicare and Medicaid drug coverage and reimbursement
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE AMPUTEE COALITION via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
education and awareness on issues of relevance to individuals with limb loss and limb difference
education and awareness on issues of relevance to individuals with limb loss and limb difference
Federal budget issues
AMERICAN OSTEOPATHIC ASSOCIATION via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
Federal budget issues
health care access and affordability, workforce reauthorization, Medicare physician payment reform, physician workforce
Medicare physician payment, graduate medical education, opioid alternatives, MedPAC, resident physician shortage
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMYLYX PHARMACEUTICALS via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
ALS and access to innovation
ALS and access to innovation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMAZON.COM SERVICES LLC via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
primary care issues, high-deductible health plan, telehealth coverage policies, tele prescribing
CMMI direct contracting program, health savings account, Medicare Advantage, Medicare Part D policy
Issues related to tax advantage savings vehicles for health expenses
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AIS HEALTHCARE via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · 4T
DEA & FDA opioid policy
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK (ACSCAN) via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
H.R.3916/S.1840 - SCREENS for Cancer Act of 2023 IRA implementation, childhood cancer, access and coverage, prescription drug pricing and access, health disparities, cancer screenings, prostate cancer screenings, PCHETA, MCED
Medicare & Medicaid policy and reimbursement issues, MCED
Federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
ABBOTT (FORMERLY KNOWN AS ALERE INC.) via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
Federal budget issues
issues related to international trade
Infant formula, diagnostics, regulation, supply chain, changes to the organ national transplant program, LDTs, Future Pharmacy, physician fee schedule reform
GENENTECH, INC. via TARPLIN, DOWNS & YOUNG, LLC
2024 · fourth_quarter · Q4
Maintaining Investments in New Innovation (MINI) Act IRA implementation, Medicare & Medicaid payment and coverage issues, CMMI, orphan drugs
IRA implementation, drug pricing and access, transparency, 340B, PAPHA reauthorization, supply chain
Federal budget issues
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AVAILITY via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
Federal cybersecurity standards regulation of clearing houses
Federal cybersecurity standards regulation of clearing houses
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
HANSA BIOPHARMA via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
Kidney issues, access to innovation, rare disease issues
Filing targets: Health & Human Services, Dept of (HHS)
SAS via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
Medicaid redeterminations, nursing home ownership transparency
Medicaid redeterminations, nursing home ownership transparency, IRA implementation, medical review pilot, data use by Medicare Administrative Contractors
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
BRISTOL MYERS SQUIBB via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
H.R. 5378: Lower Costs, More Transparency Act Prescription drug access and affordability, pricing, transparency, biosimilars, 340B
IRA implementation, Medicare & Medicaid payment and coverage issues
Federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SAREPTA THERAPEUTICS via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
Innovation, Duchenne Muscular Dystrophy, platform technologies, value based contracting, gene therapy
Federal budget issues
Medicaid drug rebate program, coverage, state program operations, waivers, gene therapy, value based contracting, Medicaid value based payment rule
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
JAZZ PHARMACEUTICALS INC. via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
H.R. 8467 - Farm, Food, and National Security Act of 2024 Drug safety, prescription drug abuse, value of prescription drugs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BREAKTHROUGH T1D (FKA JUVENILE DIABETES RESEARCH FOUNDATION INTERNATIONAL) via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
S.1269 - INSULIN Act of 2023 S.1855 Special Diabetes Program Reauthorization Act of 2023 S.4504/H.R.8698 Strengthening Collective Resources for Encouraging Education Needed (SCREEN) for Type 1 Diabetes Act Issues related to insulin affordability and cell and gene therapies
H.R. 2872 - Further Additional Continuing Appropriations and Other Extensions Act, 2024 H.R. 4366 - Consolidated Appropriations Act of 2024 H.R. 7463 - the Extension of Continuing Appropriations and Other Matters Act S. 4942 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2025 Issues pertaining to NIH appropriations for FY25
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HANSA BIOPHARMA via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · RR
Kidney issues, rare disease issues
AMGEN INC via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
IRA implementation, 340B, biosimilars, orphan drugs, prescription drug access & reimbursement, FDA issues, transparency
Medicare coverage and reimbursement issues, Medicare Part B reimbursement, transparency, prescription drug pricing and access, 340B
federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ASTRAZENECA via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
Medicare and Medicaid drug coverage and reimbursement
IRA implementation, 340B, orphan drug issues, oncology, transparency
Federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CRINETICS PHARMACEUTICALS via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
Medicare policy
Innovation, prescription drug pricing
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
HIMS & HERS HEALTH, INC. via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · 3T
Telehealth, direct-to-consumer product regulation, distribution
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMYLYX PHARMACEUTICALS via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
ALS and access to innovation
ALS and access to innovation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE AMPUTEE COALITION via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
education and awareness on issues of relevance to individuals with limb loss and limb difference
education and awareness on issues of relevance to individuals with limb loss and limb difference
veterans, disability policy
AMERICAN OSTEOPATHIC ASSOCIATION via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
Medicare physician payment, graduate medical education, opioid alternatives, MedPAC, resident physician shortage
Federal budget issues
health care access and affordability, workforce reauthorization, Medicare physician payment reform, physician workforce
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
TRIPLE-S MANAGEMENT CORPORATION via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
Federal budget issues
Medicare Advantage, Medicare Advantage benchmarks, Medicare reimbursement, dual eligible, Medicare physician payment
health disparities, social determinates of health
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
QUEST DIAGNOSTICS via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
diagnostics, clinical lab reimbursement issues, savings access to lab service
physician fee schedule
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PHRMA via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
Federal budget issues
Medicare & Medicaid payment and coverage issues, transparency, 340B
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, supply chain integrity, innovation, 340B, transparency
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL SEATING & MOBILITY via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
mobility issues, durable medical equipment
mobility issues, durable medical equipment
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LONGEVITY HEALTH PLAN via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
S. 3950 Duels Act of 2024 institutional special needs plans, Medicare Advantage, network adequacy, duel eligibles
institutional special needs plans issues and policies
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
LINCARE via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
Federal budget issues
competitive bidding, durable medical equipment, Medicare coverage and reimbursement, home care, remote patient monitoring
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HEALTH CARE SERVICE CORPORATION via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
Medicare & Medicaid payment and coverage issues, Medicare Advantage
access and affordability
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
GENTIVA (FORMERLY REPORTED AS HUMANA & KINDRED AT HOME) via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
hospice care
hospice reimbursement and policy issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
GAINWELL TECHNOLOGIES (FKA HEALTH MANAGEMENT SYSTEMS) via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
Program integrity, redeterminations, Medicaid payment and policies, federal employee health benefit program auditing
Federal budget issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
FOUNDATION MEDICINE via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
LDT, companion diagnostics, testing, innovation, lab transparency, PAPHA reauthorization, early detection screening
companion diagnostics, payment issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EVERGREEN NEPHROLOGY via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
Federal budget issues
Medicare reimbursement
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ELEVANCE HEALTH, INC (F.K.A. ANTHEM, INC. & WELLPOINT, INC.) via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
access and affordability, hospital payment policy, telehealth, coverage, social determinates of health, health savings accounts
Federal budget issues
Medicare & Medicaid reimbursement and coverage issues, Medicare Advantage
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
CARDINAL HEALTH (F.K.A. THE GLOVER PARK GROUP) via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
General issues related to drug shortages, supply chain
federal budget issues
Filing targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BIOTECHNOLOGY INDUSTRY ORGANIZATION via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
Medicare & Medicaid payment and coverage issues
Federal budget issues
IRA implementation, innovation, 340B, orphan drugs, PAPHA reauthorization, competitiveness, supply chain
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
BLUE CROSS BLUE SHIELD ASSOCIATION via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
Federal budget issues
Medicare & Medicaid payment and coverage issues
Medicare Advantage, telehealth, coverage, health savings accounts
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BD (BECTON, DICKINSON AND COMPANY) via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
supply chain, US competitiveness
product shortages related to EPA regulations
Medicare coverage and reimbursement, diagnostics
ELI LILLY AND COMPANY via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, non-interference, drug shortages, prescription drug access and affordability, transparency, insulin policy, 340B
H.R.4818 - Treat and Reduce Obesity Act of 2023 Medicare & Medicaid payments and coverage issues, Medicare Part D, Medicare Part B, 340B
Federal budget issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OPTION CARE HEALTH via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
H.R.4104/S.1976 - Preserving Patient Access to Home Infusion Act Medicare coverage and payment for home infusion services
Federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ADVAMED via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
Medicare coverage regulation and reimbursement of imaging services, Medicare physician payment, equipment maintenance, coding, parallel review, diagnostic endpoints, HOPPS, packaging, nuclear medicine, radiopharmaceuticals, E&M codes/budget neutrality, AI coverage and reimbursement
Imaging policy, mobile medical apps, device regulation, innovation, radiopharmaceuticals, coverage decisions, AI, device shortages, device servicing and manufacturing
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ACCENTURE FEDERAL SERVICES via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
federal budget issues, changes to the organ national transplant program
operational and contract issues
Filing targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
AMNEAL PHARMACEUTICALS, INC. via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
drug shortages, critical medicines limited to antibiotics and antimicrobials
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BOEHRINGER INGELHEIM via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
S. 723 Access to Prescription Drug Therapeutics Act Medicare & Medicaid coverage and payment issues, regulatory and payment issues, IRA implementation
H.R. 5378: Lower Costs, More Transparency Act IRA implementation, prescription drug pricing, prescription drug access and affordability, transparency, 340B
Federal budget issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THORN RUN PARTNERS (ON BEHALF OF THE PARTNERSHIP TO IMPROVE PATIENT CARE) via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
H.R.485 - Protecting Health Care for All Patients Act of 2023 IRA implementation, patient engagement, alternative payment models
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALZHEIMER'S ASSOCIATION via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
care planning, home and community based care, innovation, NAPA, BOLD Act, Advancing America's Interests Act
Medicare & Medicaid coverage and reimbursement issues
federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
EXCELLUS HEALTH PLAN, INC. via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
H.R.8561 Medicare Advantage, Medicare reimbursement and payment issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
Opioid Abuse - General issues related to opioid abuse and access to medication assisted treatment HR 1770/S. 2477 - Equitable Community Access to Pharmacist Services Act Implementation of Public Law 113-54 (DSCSA)
HR 405 Essential Medicines Strategic Stockpile Act of 2023 HR 3837 Improving Public Health Preparedness Act HR 3557: Medical and Health Stockpile Accountability Act HR 3631/S 2080: State Strategic Stockpile Act HR 4421: Reauthorization of the Pandemic All-Hazards Preparedness Act H.R.4531/S. 2433 - Support for Patients and Communities Reauthorization Act S.2510 - RAPID Reserve Act HR 6992/S. 2364 - MAPS Act H.R.9540 - Fight Illicit Pill Presses Act of 2024 H.R. 8261, the Preserving Telehealth, Hospital, and Ambulance Access Act H.R. 7623, Telehealth Modernization Act of 2024 General Issues Related to Drug Shortages including Senate Finance Proposal and Drug Shortages Appropriations Requests General Issues Related to the Strategic National Stockpile
NOVOCURE INC. via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
IRA implementation, FDA policies
Medicare coverage and reimbursement, national coverage determinations, skilled nursing facility bundled payment policy
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
SANOFI US SERVICES INC (FORMERLY KNOWN AS GENZYME CORPORATION) via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
orphan drug tax credit, VICP
IRA implementation, transparency, vaccines, coverage and access
federal budget issues
VALNEVA USA, INC via TARPLIN, DOWNS & YOUNG, LLC
2024 · third_quarter · Q3
S.2080 Strengthening America's Strategic National Stockpile Act H.R.3631 State Strategic Stockpile Act vaccine access, pandemic preparedness, PAHPA reauthorization
Federal budget issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
IRA implementation, Medicare and Medicaid payment and coverage issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
Medicare & Medicaid reimbursement and coverage issues, Medicare Advantage
access and affordability, hospital payment policy, telehealth, coverage, social determinates of health, health savings accounts
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
product shortages related to EPA regulations
Federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
veterans, disability policy
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EPA rule making
Medicare reimbursement, Medicare competitive bidding for diabetic supplies, diagnostics, PAMA, Self-testing, Nutrition, Emerging medical device technology, National Coverage Decisions
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Federal budget issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
IRA implementation, diagnostics, supply chain, privacy
Federal budget issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
IRA implementation, supply chain integrity, 340B, orphan drugs, newborn screening, expanded access, transparency, drug shortages, drug pricing, insulin, diabetes screening, COPD
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE